Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA TrialMichael C. Kreißl, Martin Schlumberger, Lars Bastholt et al.|Journal of Clinical Oncology|2020Cited by 61
Erectile Dysfunction in Patients Treated with Selpercatinib for <i>RET</i> -Altered Thyroid CancerAntonio Matrone, Rossella Elisei, Cyrus Sayehli et al.|Thyroid|2024Cited by 6